PD98059 (C007B-402730)

Catalog No.: C007B-402730
Mfr. No.: P126620-2mg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $31.80

List Price: $35.33

PD98059 is a non-ATP competitive MEK inhibitor with IC50 of 2 μM in a cell-free assay, specifically inhibits MEK-1-mediated activation of MAPK: does not directly inhibit ERK1 or ERK2.A selective inhibitor of MEK and blocker of MAP.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

PD98059 is a non-ATP competitive MEK inhibitor with IC50 of 2 μM in a cell-free assay, specifically inhibits MEK-1-mediated activation of MAPK; does not directly inhibit ERK1 or ERK2.A selective inhibitor of MEK and blocker of MAP. Specification: ≥98% MDL Number: MFCD00671789 Molecular Formula: C16H13NO3 Molecular Weight: 267.28 PubChem CID: 4713 Isomeric SMILES: COC1=CC=CC(=C1N)C2=CC(=O)C3=CC=CC=C3O2 Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/P126620-SCI_e6350bf2ccaaf066a89e4f5eed73af19.pdf

UPC:: 51112003
Condition:: New
Availability:: 2 weeks
Weight:: 1.06 Ounces
HazmatClass:: Yes
WeightUOM:: LB
MPN:: P126620-2mg
CAS:: 167869-21-8
Health Hazards:: Toxic
Product Size:: 2mg
Hazard Statement Codes:: H301
Precautionary Statement Codes:: P264:P270:P330:P405:P501

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."